IN2014MN00938A - - Google Patents
Info
- Publication number
- IN2014MN00938A IN2014MN00938A IN938MUN2014A IN2014MN00938A IN 2014MN00938 A IN2014MN00938 A IN 2014MN00938A IN 938MUN2014 A IN938MUN2014 A IN 938MUN2014A IN 2014MN00938 A IN2014MN00938 A IN 2014MN00938A
- Authority
- IN
- India
- Prior art keywords
- controlled
- release
- specific chelator
- drug
- manipulating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
This invention provides the controlled release method for a pharmaceutical composition comprising of metals in the drug carrier. The specific chelator is used to trigger the release of active pharmaceutical ingredients from chelating complex micelles. The drug release rate and half life can also be controlled by manipulating the dosing sequence and the concentration of metal and specific chelator.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261694216P | 2012-08-28 | 2012-08-28 | |
PCT/US2013/024049 WO2014035465A1 (en) | 2012-08-28 | 2013-01-31 | The controlled release method for a pharmaceutical composition composed of chelating complex micelles |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN00938A true IN2014MN00938A (en) | 2015-04-24 |
Family
ID=50184076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN938MUN2014 IN2014MN00938A (en) | 2012-08-28 | 2013-01-31 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9597406B2 (en) |
EP (1) | EP2890400A4 (en) |
JP (1) | JP6251689B2 (en) |
KR (1) | KR101628586B1 (en) |
CN (1) | CN105102001B (en) |
AU (2) | AU2013309496A1 (en) |
BR (1) | BR112014013184A2 (en) |
CA (1) | CA2854927A1 (en) |
IL (1) | IL232973B (en) |
IN (1) | IN2014MN00938A (en) |
TW (1) | TWI568454B (en) |
WO (1) | WO2014035465A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104492393B (en) * | 2014-11-13 | 2016-11-09 | 程金生 | Flavonoid substances separation method in Camellia nitidissima Chi based on magnetic nano-particle-PAMAM nano composite material |
US20190022103A1 (en) * | 2014-12-22 | 2019-01-24 | Mordechai Chevion | New metal complexes of nocardamine and their use in pharmaceutical compositions |
WO2016168993A1 (en) | 2015-04-22 | 2016-10-27 | Innolife Co., Ltd. | Methods of tissue repair and regeneration |
WO2017049529A1 (en) | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
KR101990060B1 (en) * | 2017-07-21 | 2019-09-30 | 주식회사 송이산업 | Method for preparation of resveratrol nano-capsue and the nano-capsule therefrom |
CN107670036B (en) * | 2017-09-30 | 2020-12-08 | 中国科学院长春应用化学研究所 | Dissociation method of iron coordination polymer nanoparticles and application thereof |
ES2914305T3 (en) | 2017-12-26 | 2022-06-09 | Ind Tech Res Inst | Composition to improve the solubility of poorly soluble substances, use thereof and complex formulation containing the same |
KR102067551B1 (en) * | 2018-04-12 | 2020-01-17 | (주) 에프엔지리서치 | Compounds for remediating the contaminated soil or water |
CN109528637A (en) * | 2018-12-20 | 2019-03-29 | 江西润泽药业有限公司 | Levofloxacin Hydrochloride Injection and preparation method thereof |
KR20200106607A (en) * | 2019-03-05 | 2020-09-15 | 주식회사 코아팜바이오 | A pharmaceutical composition comprising oseltamivir |
KR102373590B1 (en) | 2020-09-22 | 2022-03-14 | (주)아이엠지티 | Novel nanoparticles using anionic polymers, preparation method and composition thereof |
TW202310881A (en) * | 2021-09-09 | 2023-03-16 | 原創生醫股份有限公司 | Metal complex for ultrasound imaging and use thereof |
CN113712975B (en) * | 2021-09-12 | 2023-08-29 | 东北农业大学 | New use of amifostine as NDM-1 inhibitor or antibiotic protectant |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7749485B2 (en) | 2004-06-03 | 2010-07-06 | Bracco Research S.A. | Liposomal assembly for therapeutic and/or diagnostic use |
US20060141054A1 (en) * | 2004-10-25 | 2006-06-29 | Thomas Piccariello | Metal coordinated compositions |
ES2332062T3 (en) * | 2005-04-01 | 2010-01-25 | Intezyne Technologies Incorporated | POLYMER MICELLS FOR THE SUPPLY OF PHARMACOS. |
US8252846B2 (en) * | 2005-05-10 | 2012-08-28 | Emory University | Strategies for delivery of active agents using micelles and particles |
EP1983973B1 (en) * | 2006-02-17 | 2012-10-24 | SRI International | Oral dtpa for radionuclide chelation |
JP2011505896A (en) * | 2007-12-07 | 2011-03-03 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Polymeric drug carriers for image-guided delivery |
EP2265256A1 (en) | 2008-03-17 | 2010-12-29 | University of Utah Research Foundation | Dithiocarbamate metal chelates and methods of making and using thereof |
EP2161020A1 (en) * | 2008-09-09 | 2010-03-10 | Koninklijke Philips Electronics N.V. | Chelating amphiphilic polymers |
TWI568453B (en) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | A drug carrier with chelating complex micelles and the application thereof |
-
2013
- 2013-01-31 AU AU2013309496A patent/AU2013309496A1/en not_active Abandoned
- 2013-01-31 CA CA2854927A patent/CA2854927A1/en not_active Abandoned
- 2013-01-31 KR KR1020147009553A patent/KR101628586B1/en active IP Right Grant
- 2013-01-31 EP EP13833140.0A patent/EP2890400A4/en not_active Withdrawn
- 2013-01-31 JP JP2014555695A patent/JP6251689B2/en active Active
- 2013-01-31 WO PCT/US2013/024049 patent/WO2014035465A1/en active Application Filing
- 2013-01-31 TW TW102103662A patent/TWI568454B/en active
- 2013-01-31 IN IN938MUN2014 patent/IN2014MN00938A/en unknown
- 2013-01-31 CN CN201380003961.1A patent/CN105102001B/en active Active
- 2013-01-31 BR BR112014013184A patent/BR112014013184A2/en not_active IP Right Cessation
- 2013-01-31 US US14/346,815 patent/US9597406B2/en active Active
-
2014
- 2014-06-05 IL IL232973A patent/IL232973B/en active IP Right Grant
-
2016
- 2016-04-13 AU AU2016202303A patent/AU2016202303B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP6251689B2 (en) | 2017-12-20 |
BR112014013184A8 (en) | 2017-06-27 |
AU2016202303B2 (en) | 2017-03-02 |
EP2890400A4 (en) | 2016-04-06 |
US9597406B2 (en) | 2017-03-21 |
KR20140107179A (en) | 2014-09-04 |
AU2013309496A1 (en) | 2014-06-05 |
CA2854927A1 (en) | 2014-03-06 |
KR101628586B1 (en) | 2016-06-08 |
CN105102001A (en) | 2015-11-25 |
JP2015509928A (en) | 2015-04-02 |
EP2890400A1 (en) | 2015-07-08 |
CN105102001B (en) | 2017-12-26 |
TW201408338A (en) | 2014-03-01 |
TWI568454B (en) | 2017-02-01 |
WO2014035465A1 (en) | 2014-03-06 |
BR112014013184A2 (en) | 2017-06-13 |
IL232973A0 (en) | 2014-07-31 |
US20140212371A1 (en) | 2014-07-31 |
IL232973B (en) | 2018-06-28 |
AU2016202303A1 (en) | 2016-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN00938A (en) | ||
PH12015502615B1 (en) | Chemical compounds | |
PH12014502778A1 (en) | Antibody formulation | |
PH12018500422A1 (en) | Rapid-acting insulin compositions | |
MX366899B (en) | New compounds. | |
CL2014000279A1 (en) | Fertilizer of cohesive potassium muriate containing micronutrients; and method of preparation thereof. | |
GB201316021D0 (en) | Vitamin D composition | |
GB201200718D0 (en) | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof | |
IL232729B (en) | Drug carrier with chelating composite micelle, pharmaceutical composition containing same and method of manufacture thereof | |
HK1245276B (en) | Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment | |
PH12014502407A1 (en) | New alfentanil composition for the treatment of acute pain | |
MX2015003034A (en) | Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same. | |
NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
MX2015016410A (en) | Esters of oligo-hydroxycarboxylic acids and use thereof. | |
EP3132797A4 (en) | Use of composition containing iron (ii) amino acid chelate in preparation of drug for ameliorating diabetes | |
MX2014009015A (en) | Stable amorphous raltegravir potassium premix and process for the preparation thereof. | |
GR1008167B (en) | Pharmaceutical gluconic iron-containing composition - preparation method of same | |
IN2014DN07897A (en) | ||
MX2019001701A (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine. | |
PH12015500070B1 (en) | Pediatric oral liquid compositions containing nepadutant | |
UA106101C2 (en) | Method for the preparation of antiviral preparations containing inorganic active ingredients as ceric oxide nanoparticles | |
TH149370B (en) | Kalmagafodipers, novel chemical drugs, and other alloy complexes, methods of preparation, composition, and treatment methods. (Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment) | |
NZ712318A (en) | Coated phenylephrine particles and use thereof in pharmaceutical formulations | |
TW201612522A (en) | Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel | |
GB201105942D0 (en) | The invention relates to the manufacture and use of an aqueous based metal ion chelating medicament that can be used for the treatment of Clostridium |